Quick facts
- Immunohistochemistry reagents and kits are the antibodies, detection systems and controls that a laboratory uses to stain a tissue section and read the presence of a specific protein in the cells.
- United States: general immunohistochemistry reagents and kits are a named entry at 21 CFR 864.1860 in Class I, while the specific assay kits inside the same section are placed in Class II or Class III.
- Canada: an assay used in the screening for or diagnosis of cancer reaches Class III through Rule 4(a) of Part 2 of Schedule 1 to the Medical Devices Regulations, SOR-98-282.
- The gap is wide: the general reagent is Class I in the United States, and the cancer-diagnostic assay it feeds reaches Class III in Canada, because the two rulebooks sort the same bench by different questions.
- The same section of the United States rules carries a reagent, a control material, an assay kit and an image-analysis microscope, so the class is read per entry and never across the section.
- The entry and rule text below were checked against the current CFR text and the Regulations on 2026-10-10.
Immunohistochemistry is the bench step that shows where a protein sits inside a tissue section. A laboratory brings an antibody to the slide, builds a visible signal from it, and reads the stained cells under a microscope, and the answer is used in a diagnosis. The reagents that carry the step are filed as devices in both countries, but the two rulebooks sort the bench in different ways: one names the reagent in a low-risk entry, and the other reads the use the answer is put to. This article sets out what the bench does, how each rulebook files it, and what a laboratory should be able to point at when a new reagent is brought in and when a stained slide is released.
What are immunohistochemistry reagents and kits?
The bench step begins with a tissue section on a slide. An antibody that binds a chosen protein is applied, a detection system builds an enzyme or a fluorophore onto the bound antibody, and a colour or a glow marks the cells that carry the protein. The laboratory reads the pattern under a microscope and reports it. The kit is the set of reagents, the control and the instructions that make the step reproducible from run to run.
Two sizes of device sit on the bench. The general reagents, such as an unlabelled detection system, a buffer or a control, are bought as bench stock and used across many assays. The assay-specific kits, such as a kit that reads a receptor in a breast specimen, are bought for one target and carry the claim that ties the result to a diagnosis. The same section of the United States rules holds both, and the class is read per entry.
The device is an in vitro diagnostic device. It examines a specimen outside the body, it does not enter the body, and its output is a diagnostic one. That fact is what puts it in the diagnostic family, and the two countries sort that family in two different ways.
How does the United States classify immunohistochemistry reagents and kits?
The United States sorts the bench by entry. 21 CFR 864.1860 covers "Immunohistochemistry reagents and kits," and the general reagents and kits inside it are placed in Class I; the same section also holds assay kits that are placed in Class II and Class III according to the target they read.
| Entry inside 21 CFR 864.1860 | Product code | Class | Where it is used |
|---|---|---|---|
| Immunohistochemistry reagents and kits | NJT | Class I | General bench reagents and detection systems |
| Immunohistochemistry assay, antibody to estrogen receptor | MYA | Class II | Receptor status in a tissue section |
| Immunohistochemistry assay, antibody to HER2/neu | MXZ | Class II | Receptor status in a tissue section |
| Immunohistochemistry test, DNA mismatch repair protein assay | QNH | Class III | Mismatch repair status in a tumour |
A buyer who reads only the first row sees Class I and stops. The section is the reason a laboratory should name the assay it runs: a general reagent and a cancer-diagnostic assay sit in the same section and read two different classes.
How does Canada classify the same bench?
Canada reaches the answer from the Rules in Part 2 of Schedule 1, which classify in vitro diagnostic devices by the use they are put to. An assay used to read a receptor that guides cancer treatment, or to screen for or diagnose cancer, is used in the screening for or diagnosis of cancer, and Rule 4(a) of Part 2 lifts such a device to Class III. A general reagent that carries no cancer claim and is used across many assays is not caught by that exception.
The exceptions in Rule 4 are worth naming because they explain the class. A diagnostic device reaches Class III where it is used in screening for or diagnosis of cancer, for genetic testing, in screening for congenital disorders in the fetus, where an erroneous result could cause death or severe disability, for disease staging, or where it monitors a drug or component with an imminent life-threatening risk. Everything else that is used in diagnosis or patient management stays in Class II.
That is the whole contrast. The Canadian bench reads the use, so a general reagent drops to the residual class while a cancer-diagnostic assay rises with the claim; the United States bench reads the entry, so the same section carries a Class I reagent and a Class III assay side by side.
Which rules decide the class in each country?
The two lists can be put side by side, because they answer the same question from different materials.
| Question | Canada | United States |
|---|---|---|
| What files the device | The use the assay is put to | The entry inside the section |
| Class of a general reagent | Residual class, where no exception applies | Class I, 21 CFR 864.1860 |
| Class of a cancer-diagnostic assay | Class III, by Rule 4(a) of Part 2 | Class II or Class III, per entry |
| Basis of the class | Screening for or diagnosis of cancer | The named entry the assay sits under |
| Maker's path | Device licence under section 32, supported by an ISO 13485 certificate | Premarket notification for the entry, unless the product code is exempt |
Read across, the columns agree that the bench holds more than one class and disagree on what sets the class. The Canadian column is a rule that follows the claim; the United States column is a set of entries that fix the class before the laboratory opens the box.
Do Canada and the United States use the same immunohistochemistry standards?
The technical layer is shared. ISO 13485:2016 sets the quality management system behind the manufacturer's records, and ISO 14971:2019 sets the risk management process behind the design file. The way a laboratory validates a new antibody lot, runs a control section with each batch and scores the stained slide is drawn from the same body of laboratory practice in both countries.
The point where the two rulebooks diverge is the paperwork behind the claim, not the staining step. The class of a device does not set the antibody dilution, the retrieval step or the scoring rule; those come from the method the laboratory validates and the manufacturer's instructions. A supplier that quotes a class as a scoring rule is quoting something the class does not carry.
What does a laboratory check before it brings in a reagent?
A laboratory bringing a new reagent onto the bench works through three checks. First, confirm the use the assay is put to, because a cancer-diagnostic assay and a general reagent read two different classes in Canada. Second, confirm the control, because a run without the control section cannot be read against the reference. Third, confirm the lot and the storage, because an antibody that has drifted out of its storage range stains weakly and reads as a loss of the target.
A laboratory that also runs a tissue-processing line keeps the reagent fridge beside the cassettes and the slides, so the sample, the section and the stain are drawn from one bench. Keeping the three on one shelf is the simple fix that carries across both countries.
Which consumables does a histology bench restock?
The reagent is one line on a bench that turns over quickly. A laboratory restocks the sterile polystyrene petri dishes used to hold sections and smears, the graduated leak-proof specimen cups that carry a specimen in from the collection room, and the sterile screw-cap specimen containers that hold the fixative and the processing fluids. The sterile 15 mL centrifuge tubes run the wash steps that clear the section between reagents. Laboratories and multi-site groups ordering at case level use the wholesale ordering page, and the B2B wholesale collection lists the lines held for institutional buyers. Reselling? become a distributor.
Sources
- 21 CFR 864.1860, immunohistochemistry reagents and kits
- openFDA device classification API
- Medical Devices Regulations, SOR/98-282, full text and Schedule 1
- US FDA, medical devices
- US FDA, medical device databases
- US FDA, overview of device regulation
- Health Canada, medical devices
- Standards Council of Canada
- CSA Group
- ISO 13485:2016, medical devices quality management
- ISO 14971:2019, risk management of medical devices
- Clinical and Laboratory Standards Institute
- Public Health Ontario, infection prevention and control
- World Health Organization
- US CDC, laboratory quality
- CCOHS, OSH answers
A stained slide is released against a control, and the printable reagent and control log is a blank form with columns for the date, the reagent, the lot, the control section, the result and the releasing pathologist, so a laboratory can show the control that stood behind the slide.
The reagent and control log generator on the same page sizes the form to the number of antibodies a laboratory runs, so a two-antibody bench and a full panel print the same sheet at two volumes.
Every laboratory and every panel differ. Ask a compliance specialist and you will get a written answer specific to your equipment and province, with the regulation or standard it is based on cited.
Related reading
- Laboratory quality control materials in Canada vs the US: which class
- Culture media, differential and selective, in Canada vs the US: which rules
- Cell and tissue culture flasks in Canada vs the US: which rules
CliniEco Medical supplies eye care, laboratory and dental consumables of the kind described in this article. MDEL #35334. This article is written for optometry, laboratory and procurement professionals and is not legal advice; the class of a device and the records kept by a practice belong to the manufacturer and to the requirements that apply to it.
Frequently Asked Questions
What class are general immunohistochemistry reagents in the United States?
They are a named entry at 21 CFR 864.1860, Immunohistochemistry reagents and kits, and the general reagents and kits inside that entry are Class I.
What class is an immunohistochemistry assay in Canada?
An assay used in the screening for or diagnosis of cancer reaches Class III through Rule 4(a) of Part 2 of Schedule 1 to the Medical Devices Regulations.
Can one section of the United States rules hold more than one class?
Yes. 21 CFR 864.1860 holds a Class I general reagent, Class II assay kits such as a receptor antibody, and Class III assay kits such as a mismatch repair test, so the class is read per entry.
What lifts a diagnostic device to Class III in Canada?
Rule 4 of Part 2 lifts a device to Class III for cancer screening or diagnosis, genetic testing, fetal congenital screening, a risk of death or severe disability, disease staging, or certain drug monitoring.
Does the reagent enter the body?
No. The reagent acts on a tissue section outside the body, so it is an in vitro diagnostic device rather than a device that enters the body.
What should a laboratory record for a stained run?
Record the date, the reagent, the lot, the control section and the result, so the control behind the slide can be shown from the log.